APO Research
Talk to an analyst

APO RESEARCH · REPORT

Vaccines

A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.

Selected research

Industry Growth & Trends

Global Vaccines Industry Growth and Trends Forecast to 2032

1 January 2026101 pages

Choose your research edition.

Industry ResearchVaccines Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Vaccines Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Vaccines Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Vaccines Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.

The major players in global Vaccines market include Merck, GSK, Sanofi, etc. The top 3 players occupy about 45% shares of the global market. North America and Europe are main markets, they occupy about 65% of the global market. Recombinant Vaccines is the main type, with a share about 35%. Rabies vaccine, Influenza vaccine, HPV vaccine are main applications, which hold a share about 35%.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Vaccines market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Vaccines market size, estimates, and forecasts are presented in terms of sales volume (K Pcs) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Vaccines market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Vaccines.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Vaccines market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Vaccines Market by Company

GSK

Sanofi

Merck

Pfizer

Novartis(GSK)

CSL

MedImmune LLC

J&J(Crucell)

China National Biotec

Tiantan

Hualan

Kangtai

Hissen

Jintan

Vaccines Segment by Type

Recombinant Vaccines

Viral Vaccines

Polysaccharide Vaccines

Others

Vaccines Segment by Application

Rabies vaccine

Influenza vaccine

HPV vaccine

Hepatitis B

Hepatitis A

Leprosy vaccine

Polio vaccine

JE vaccine

Others

Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Recombinant Vaccines Table 2. Major Company of Viral Vaccines Table 3. Major Company of Polysaccharide Vaccines Table 4. Major Company of Others Table 5. Global Vaccines Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Vaccines Sales by Type (2021-2026) & (K Pcs) Table 7. Global Vaccines Sales Market Share in Volume by Type (2021-2026) Table 8. Global Vaccines Sales by Type (2021-2026) & (US$ Million) Table 9. Global Vaccines Sales Market Share in Value by Type (2021-2026) Table 10. Global Vaccines Price by Type (2021-2026) & (US$/Pcs) Table 11. Global Vaccines Sales by Type (2027-2032) & (K Pcs) Table 12. Global Vaccines Sales Market Share in Volume by Type (2027-2032) Table 13. Global Vaccines Sales by Type (2027-2032) & (US$ Million) Table 14. Global Vaccines Sales Market Share in Value by Type (2027-2032) Table 15. Global Vaccines Price by Type (2027-2032) & (US$/Pcs) Table 16. North America Vaccines Sales by Type (2021-2026) & (K Pcs) Table 17. North America Vaccines Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Vaccines Sales by Type (2021-2026) & (K Pcs) Table 19. Europe Vaccines Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Vaccines Sales by Type (2021-2026) & (K Pcs) Table 21. Asia-Pacific Vaccines Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Vaccines Sales by Type (2021-2026) & (K Pcs) Table 23. Latin America Vaccines Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Vaccines Sales by Type (2021-2026) & (K Pcs) Table 25. Middle East and Africa Vaccines Sales by Type (2021-2026) & (US$ Million) Table 26. Vaccines Industry Trends Table 27. Vaccines Industry Drivers Table 28. Vaccines Industry Opportunities and Challenges Table 29. Vaccines Industry Restraints Table 30. Global Vaccines Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Vaccines Revenue Market Share by Company (2021-2026) Table 32. Global Vaccines Sales by Company (2021-2026) & (K Pcs) Table 33. Global Vaccines Sales Share by Company (2021-2026) Table 34. Global Vaccines Market Price by Company (2021-2026) & (US$/Pcs) Table 35. Global Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Vaccines Major Company Production Sites and Headquarters Table 37. Global Vaccines Company, Product Type & Application Table 38. Global Vaccines Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Vaccines Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Vaccines Sales by Region (2021-2026) & (K Pcs) Table 43. Global Vaccines Sales Market Share in Volume by Region (2021-2026) Table 44. Global Vaccines Sales by Region (2021-2026) & (US$ Million) Table 45. Global Vaccines Sales Market Share in Value by Region (2021-2026) Table 46. Global Vaccines Sales (K Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 47. Global Vaccines Sales by Region (2027-2032) & (K Pcs) Table 48. Global Vaccines Sales Market Share in Volume by Region (2027-2032) Table 49. Global Vaccines Sales by Region (2027-2032) & (US$ Million) Table 50. Global Vaccines Sales Market Share in Value by Region (2027-2032) Table 51. Global Vaccines Sales (K Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2027-2032) Table 52. Global Vaccines Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Vaccines Sales by Application (2021-2026) & (K Pcs) Table 54. Global Vaccines Sales Market Share in Volume by Application (2021-2026) Table 55. Global Vaccines Sales by Application (2021-2026) & (US$ Million) Table 56. Global Vaccines Sales Market Share in Value by Application (2021-2026) Table 57. Global Vaccines Price by Application (2021-2026) & (US$/Pcs) Table 58. Global Vaccines Sales by Application (2027-2032) & (K Pcs) Table 59. Global Vaccines Sales Market Share in Volume by Application (2027-2032) Table 60. Global Vaccines Sales by Application (2027-2032) & (US$ Million) Table 61. Global Vaccines Sales Market Share in Value by Application (2027-2032) Table 62. Global Vaccines Price by Application (2027-2032) & (US$/Pcs) Table 63. North America Vaccines Sales by Application (2021-2026) & (K Pcs) Table 64. North America Vaccines Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Vaccines Sales by Application (2021-2026) & (K Pcs) Table 66. Europe Vaccines Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Vaccines Sales by Application (2021-2026) & (K Pcs) Table 68. Asia-Pacific Vaccines Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Vaccines Sales by Application (2021-2026) & (K Pcs) Table 70. Latin America Vaccines Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Vaccines Sales by Application (2021-2026) & (K Pcs) Table 72. Middle East and Africa Vaccines Sales by Application (2021-2026) & (US$ Million) Table 73. GSK Company Information Table 74. GSK Business Overview Table 75. GSK Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 76. GSK Vaccines Product Portfolio Table 77. GSK Recent Development Table 78. Sanofi Company Information Table 79. Sanofi Business Overview Table 80. Sanofi Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 81. Sanofi Vaccines Product Portfolio Table 82. Sanofi Recent Development Table 83. Merck Company Information Table 84. Merck Business Overview Table 85. Merck Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 86. Merck Vaccines Product Portfolio Table 87. Merck Recent Development Table 88. Pfizer Company Information Table 89. Pfizer Business Overview Table 90. Pfizer Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 91. Pfizer Vaccines Product Portfolio Table 92. Pfizer Recent Development Table 93. Novartis(GSK) Company Information Table 94. Novartis(GSK) Business Overview Table 95. Novartis(GSK) Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 96. Novartis(GSK) Vaccines Product Portfolio Table 97. Novartis(GSK) Recent Development Table 98. CSL Company Information Table 99. CSL Business Overview Table 100. CSL Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 101. CSL Vaccines Product Portfolio Table 102. CSL Recent Development Table 103. MedImmune LLC Company Information Table 104. MedImmune LLC Business Overview Table 105. MedImmune LLC Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 106. MedImmune LLC Vaccines Product Portfolio Table 107. MedImmune LLC Recent Development Table 108. J&J(Crucell) Company Information Table 109. J&J(Crucell) Business Overview Table 110. J&J(Crucell) Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 111. J&J(Crucell) Vaccines Product Portfolio Table 112. J&J(Crucell) Recent Development Table 113. China National Biotec Company Information Table 114. China National Biotec Business Overview Table 115. China National Biotec Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 116. China National Biotec Vaccines Product Portfolio Table 117. China National Biotec Recent Development Table 118. Tiantan Company Information Table 119. Tiantan Business Overview Table 120. Tiantan Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 121. Tiantan Vaccines Product Portfolio Table 122. Tiantan Recent Development Table 123. Hualan Company Information Table 124. Hualan Business Overview Table 125. Hualan Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 126. Hualan Vaccines Product Portfolio Table 127. Hualan Recent Development Table 128. Kangtai Company Information Table 129. Kangtai Business Overview Table 130. Kangtai Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 131. Kangtai Vaccines Product Portfolio Table 132. Kangtai Recent Development Table 133. Hissen Company Information Table 134. Hissen Business Overview Table 135. Hissen Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 136. Hissen Vaccines Product Portfolio Table 137. Hissen Recent Development Table 138. Jintan Company Information Table 139. Jintan Business Overview Table 140. Jintan Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 141. Jintan Vaccines Product Portfolio Table 142. Jintan Recent Development Table 143. North America Vaccines Market Size Growth Rate (CAGR) by Country (K Pcs): 2021 VS 2025 VS 2032 Table 144. North America Vaccines Sales by Country (2021-2026) & (K Pcs) Table 145. North America Vaccines Sales Market Share by Country (2021-2026) Table 146. North America Vaccines Sales Forecast by Country (2027-2032) & (K Pcs) Table 147. North America Vaccines Sales Market Share Forecast by Country (2027-2032) Table 148. North America Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. North America Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 150. North America Vaccines Market Share by Country (2021-2026) Table 151. North America Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. North America Vaccines Market Share Forecast by Country (2027-2032) Table 153. Europe Vaccines Market Size Growth Rate (CAGR) by Country (K Pcs): 2021 VS 2025 VS 2032 Table 154. Europe Vaccines Sales by Country (2021-2026) & (K Pcs) Table 155. Europe Vaccines Sales Market Share by Country (2021-2026) Table 156. Europe Vaccines Sales Forecast by Country (2027-2032) & (K Pcs) Table 157. Europe Vaccines Sales Market Share Forecast by Country (2027-2032) Table 158. Europe Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Europe Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 160. Europe Vaccines Market Share by Country (2021-2026) Table 161. Europe Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Europe Vaccines Market Share Forecast by Country (2027-2032) Table 163. Asia-Pacific Vaccines Market Size Growth Rate (CAGR) by Country (K Pcs): 2021 VS 2025 VS 2032 Table 164. Asia-Pacific Vaccines Sales by Country (2021-2026) & (K Pcs) Table 165. Asia-Pacific Vaccines Sales Market Share by Country (2021-2026) Table 166. Asia-Pacific Vaccines Sales Forecast by Country (2027-2032) & (K Pcs) Table 167. Asia-Pacific Vaccines Sales Market Share Forecast by Country (2027-2032) Table 168. Asia-Pacific Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Asia-Pacific Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 170. Asia-Pacific Vaccines Market Share by Country (2021-2026) Table 171. Asia-Pacific Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Asia-Pacific Vaccines Market Share Forecast by Country (2027-2032) Table 173. Latin America Vaccines Market Size Growth Rate (CAGR) by Country (K Pcs): 2021 VS 2025 VS 2032 Table 174. Latin America Vaccines Sales by Country (2021-2026) & (K Pcs) Table 175. Latin America Vaccines Sales Market Share by Country (2021-2026) Table 176. Latin America Vaccines Sales Forecast by Country (2027-2032) & (K Pcs) Table 177. Latin America Vaccines Sales Market Share Forecast by Country (2027-2032) Table 178. Latin America Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. Latin America Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 180. Latin America Vaccines Market Share by Country (2021-2026) Table 181. Latin America Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. Latin America Vaccines Market Share Forecast by Country (2027-2032) Table 183. Middle East and Africa Vaccines Market Size Growth Rate (CAGR) by Country (K Pcs): 2021 VS 2025 VS 2032 Table 184. Middle East and Africa Vaccines Sales by Country (2021-2026) & (K Pcs) Table 185. Middle East and Africa Vaccines Sales Market Share by Country (2021-2026) Table 186. Middle East and Africa Vaccines Sales Forecast by Country (2027-2032) & (K Pcs) Table 187. Middle East and Africa Vaccines Sales Market Share Forecast by Country (2027-2032) Table 188. Middle East and Africa Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 189. Middle East and Africa Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 190. Middle East and Africa Vaccines Market Share by Country (2021-2026) Table 191. Middle East and Africa Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 192. Middle East and Africa Vaccines Market Share Forecast by Country (2027-2032) Table 193. Key Raw Materials Table 194. Raw Materials Key Suppliers Table 195. Vaccines Distributors List Table 196. Vaccines Customers List Table 197. Research Programs/Design for This Report Table 198. Authors List of This Report Table 199. Secondary Sources Table 200. Primary Sources List of Figures Figure 1. Vaccines Image Figure 2. Global Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Vaccines Sales (2021-2032) & (K Pcs) Figure 5. Recombinant Vaccines Image Figure 6. Global Recombinant Vaccines Sales YoY Growth (2021-2032) & (K Pcs) Figure 7. Viral Vaccines Image Figure 8. Global Viral Vaccines Sales YoY Growth (2021-2032) & (K Pcs) Figure 9. Polysaccharide Vaccines Image Figure 10. Global Polysaccharide Vaccines Sales YoY Growth (2021-2032) & (K Pcs) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (K Pcs) Figure 13. Global Vaccines Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Vaccines Market Share by Type 2025 VS 2032 Figure 15. North America Vaccines Sales Market Share in Volume by Type in 2025 Figure 16. North America Vaccines Sales Market Share in Value by Type in 2025 Figure 17. Europe Vaccines Sales Market Share in Volume by Type in 2025 Figure 18. Europe Vaccines Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Vaccines Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Vaccines Sales Market Share in Value by Type in 2025 Figure 21. Latin America Vaccines Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Vaccines Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Vaccines Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Vaccines Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Vaccines Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Rabies vaccine Image Figure 28. Global Rabies vaccine Sales YoY Growth (2021-2032) & (K Pcs) Figure 29. Influenza vaccine Image Figure 30. Global Influenza vaccine Sales YoY Growth (2021-2032) & (K Pcs) Figure 31. HPV vaccine Image Figure 32. Global HPV vaccine Sales YoY Growth (2021-2032) & (K Pcs) Figure 33. Hepatitis B Image Figure 34. Global Hepatitis B Sales YoY Growth (2021-2032) & (K Pcs) Figure 35. Hepatitis A Image Figure 36. Global Hepatitis A Sales YoY Growth (2021-2032) & (K Pcs) Figure 37. Leprosy vaccine Image Figure 38. Global Leprosy vaccine Sales YoY Growth (2021-2032) & (K Pcs) Figure 39. Polio vaccine Image Figure 40. Global Polio vaccine Sales YoY Growth (2021-2032) & (K Pcs) Figure 41. JE vaccine Image Figure 42. Global JE vaccine Sales YoY Growth (2021-2032) & (K Pcs) Figure 43. Others Image Figure 44. Global Others Sales YoY Growth (2021-2032) & (K Pcs) Figure 45. Global Vaccines Market Size Overview by Application (2021-2032) & (US$ Million) Figure 46. Global Vaccines Market Share by Application 2025 VS 2032 Figure 47. North America Vaccines Sales Market Share in Volume by Application in 2025 Figure 48. North America Vaccines Sales Market Share in Value by Application in 2025 Figure 49. Europe Vaccines Sales Market Share in Volume by Application in 2025 Figure 50. Europe Vaccines Sales Market Share in Value by Application in 2025 Figure 51. Asia-Pacific Vaccines Sales Market Share in Volume by Application in 2025 Figure 52. Asia-Pacific Vaccines Sales Market Share in Value by Application in 2025 Figure 53. Latin America Vaccines Sales Market Share in Volume by Application in 2025 Figure 54. Latin America Vaccines Sales Market Share in Value by Application in 2025 Figure 55. Middle East and Africa Vaccines Sales Market Share in Volume by Application in 2025 Figure 56. Middle East and Africa Vaccines Sales Market Share in Value by Application in 2025 Figure 57. North America Vaccines Sales by Country: 2021 VS 2025 VS 2032 (K Pcs) Figure 58. North America Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. North America Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. North America Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Vaccines Sales by Country: 2021 VS 2025 VS 2032 (K Pcs) Figure 62. Europe Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Europe Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Europe Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Vaccines Sales by Country: 2021 VS 2025 VS 2032 (K Pcs) Figure 66. Asia-Pacific Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Asia-Pacific Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Asia-Pacific Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Latin America Vaccines Sales by Country: 2021 VS 2025 VS 2032 (K Pcs) Figure 70. Latin America Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 71. Latin America Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 72. Latin America Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 73. Middle East and Africa Vaccines Sales by Country: 2021 VS 2025 VS 2032 (K Pcs) Figure 74. Middle East and Africa Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 75. Middle East and Africa Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 76. Middle East and Africa Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 77. Vaccines Value Chain Figure 78. Key Raw Materials Price Figure 79. Manufacturing Cost Structure Figure 80. Vaccines Production Mode & Process Figure 81. Direct Comparison with Distribution Share Figure 82. Distributors Profiles Figure 83. Years Considered Figure 84. Research Process Figure 85. Key Executives Interviewed

Scope & coverage.

Types
  • Recombinant Vaccines
  • Viral Vaccines
  • Polysaccharide Vaccines
  • Others
Applications
  • Rabies vaccine
  • Influenza vaccine
  • HPV vaccine
  • Hepatitis B
  • Hepatitis A
  • Leprosy vaccine
  • Polio vaccine
  • JE vaccine
  • Others
Companies covered
  • GSK
  • Sanofi
  • Merck
  • Pfizer
  • Novartis(GSK)
  • CSL
  • MedImmune LLC
  • J&J(Crucell)
  • China National Biotec
  • Tiantan
  • Hualan
  • Kangtai
  • Hissen
  • Jintan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Vaccines Market by Type
  6. 1.3.1 Recombinant Vaccines
  7. 1.3.2 Viral Vaccines
  8. 1.3.3 Polysaccharide Vaccines
  9. 1.3.4 Others
  10. 1.4 Global Vaccines Market Size by Type
  11. 1.4.1 Global Vaccines Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Vaccines Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Vaccines Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Vaccines Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Vaccines Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Vaccines Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Vaccines Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Vaccines Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Vaccines Industry Trends
  2. 2.2 Vaccines Industry Drivers
  3. 2.3 Vaccines Industry Opportunities and Challenges
  4. 2.4 Vaccines Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Vaccines Revenue (2021-2026)
  2. 3.2 Global Top Players by Vaccines Sales (2021-2026)
  3. 3.3 Global Top Players by Vaccines Price (2021-2026)
  4. 3.4 Global Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Vaccines Major Company Production Sites & Headquarters
  6. 3.6 Global Vaccines Company, Product Type & Application
  7. 3.7 Global Vaccines Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Vaccines Tier 1, Tier 2, and Tier 3
4 Vaccines Regional Status and Outlook
  1. 4.1 Global Vaccines Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Vaccines Historic Market Size by Region
  3. 4.2.1 Global Vaccines Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Vaccines Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Vaccines Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Vaccines Forecasted Market Size by Region
  7. 4.3.1 Global Vaccines Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Vaccines Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Vaccines Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Vaccines by Application
  1. 5.1 Vaccines Market by Application
  2. 5.1.1 Rabies vaccine
  3. 5.1.2 Influenza vaccine
  4. 5.1.3 HPV vaccine
  5. 5.1.4 Hepatitis B
  6. 5.1.5 Hepatitis A
  7. 5.1.6 Leprosy vaccine
  8. 5.1.7 Polio vaccine
  9. 5.1.8 JE vaccine
  10. 5.1.9 Others
  11. 5.2 Global Vaccines Market Size by Application
  12. 5.2.1 Global Vaccines Market Size Overview by Application (2021-2032)
  13. 5.2.2 Global Vaccines Historic Market Size Review by Application (2021-2026)
  14. 5.2.3 Global Vaccines Forecasted Market Size by Application (2027-2032)
  15. 5.3 Key Regions Market Size by Application
  16. 5.3.1 North America Vaccines Sales Breakdown by Application (2021-2026)
  17. 5.3.2 Europe Vaccines Sales Breakdown by Application (2021-2026)
  18. 5.3.3 Asia-Pacific Vaccines Sales Breakdown by Application (2021-2026)
  19. 5.3.4 South America Vaccines Sales Breakdown by Application (2021-2026)
  20. 5.3.5 Middle East and Africa Vaccines Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 GSK
  2. 6.1.1 GSK Company Information
  3. 6.1.2 GSK Business Overview
  4. 6.1.3 GSK Vaccines Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 GSK Vaccines Product Portfolio
  6. 6.1.5 GSK Recent Developments
  7. 6.2 Sanofi
  8. 6.2.1 Sanofi Company Information
  9. 6.2.2 Sanofi Business Overview
  10. 6.2.3 Sanofi Vaccines Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi Vaccines Product Portfolio
  12. 6.2.5 Sanofi Recent Developments
  13. 6.3 Merck
  14. 6.3.1 Merck Company Information
  15. 6.3.2 Merck Business Overview
  16. 6.3.3 Merck Vaccines Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Merck Vaccines Product Portfolio
  18. 6.3.5 Merck Recent Developments
  19. 6.4 Pfizer
  20. 6.4.1 Pfizer Company Information
  21. 6.4.2 Pfizer Business Overview
  22. 6.4.3 Pfizer Vaccines Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Pfizer Vaccines Product Portfolio
  24. 6.4.5 Pfizer Recent Developments
  25. 6.5 Novartis(GSK)
  26. 6.5.1 Novartis(GSK) Company Information
  27. 6.5.2 Novartis(GSK) Business Overview
  28. 6.5.3 Novartis(GSK) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Novartis(GSK) Vaccines Product Portfolio
  30. 6.5.5 Novartis(GSK) Recent Developments
  31. 6.6 CSL
  32. 6.6.1 CSL Company Information
  33. 6.6.2 CSL Business Overview
  34. 6.6.3 CSL Vaccines Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 CSL Vaccines Product Portfolio
  36. 6.6.5 CSL Recent Developments
  37. 6.7 MedImmune LLC
  38. 6.7.1 MedImmune LLC Company Information
  39. 6.7.2 MedImmune LLC Business Overview
  40. 6.7.3 MedImmune LLC Vaccines Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 MedImmune LLC Vaccines Product Portfolio
  42. 6.7.5 MedImmune LLC Recent Developments
  43. 6.8 J&J(Crucell)
  44. 6.8.1 J&J(Crucell) Company Information
  45. 6.8.2 J&J(Crucell) Business Overview
  46. 6.8.3 J&J(Crucell) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 J&J(Crucell) Vaccines Product Portfolio
  48. 6.8.5 J&J(Crucell) Recent Developments
  49. 6.9 China National Biotec
  50. 6.9.1 China National Biotec Company Information
  51. 6.9.2 China National Biotec Business Overview
  52. 6.9.3 China National Biotec Vaccines Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 China National Biotec Vaccines Product Portfolio
  54. 6.9.5 China National Biotec Recent Developments
  55. 6.10 Tiantan
  56. 6.10.1 Tiantan Company Information
  57. 6.10.2 Tiantan Business Overview
  58. 6.10.3 Tiantan Vaccines Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Tiantan Vaccines Product Portfolio
  60. 6.10.5 Tiantan Recent Developments
  61. 6.11 Hualan
  62. 6.11.1 Hualan Company Information
  63. 6.11.2 Hualan Business Overview
  64. 6.11.3 Hualan Vaccines Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Hualan Vaccines Product Portfolio
  66. 6.11.5 Hualan Recent Developments
  67. 6.12 Kangtai
  68. 6.12.1 Kangtai Company Information
  69. 6.12.2 Kangtai Business Overview
  70. 6.12.3 Kangtai Vaccines Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Kangtai Vaccines Product Portfolio
  72. 6.12.5 Kangtai Recent Developments
  73. 6.13 Hissen
  74. 6.13.1 Hissen Company Information
  75. 6.13.2 Hissen Business Overview
  76. 6.13.3 Hissen Vaccines Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Hissen Vaccines Product Portfolio
  78. 6.13.5 Hissen Recent Developments
  79. 6.14 Jintan
  80. 6.14.1 Jintan Company Information
  81. 6.14.2 Jintan Business Overview
  82. 6.14.3 Jintan Vaccines Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Jintan Vaccines Product Portfolio
  84. 6.14.5 Jintan Recent Developments
7 North America by Country
  1. 7.1 North America Vaccines Sales by Country
  2. 7.1.1 North America Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Vaccines Sales by Country (2021-2026)
  4. 7.1.3 North America Vaccines Sales Forecast by Country (2027-2032)
  5. 7.2 North America Vaccines Market Size by Country
  6. 7.2.1 North America Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Vaccines Market Size by Country (2021-2026)
  8. 7.2.3 North America Vaccines Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Vaccines Sales by Country
  2. 8.1.1 Europe Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Vaccines Sales by Country (2021-2026)
  4. 8.1.3 Europe Vaccines Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Vaccines Market Size by Country
  6. 8.2.1 Europe Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Vaccines Market Size by Country (2021-2026)
  8. 8.2.3 Europe Vaccines Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Vaccines Sales by Country
  2. 9.1.1 Asia-Pacific Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Vaccines Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Vaccines Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Vaccines Market Size by Country
  6. 9.2.1 Asia-Pacific Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Vaccines Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Vaccines Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Vaccines Sales by Country
  2. 10.1.1 South America Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Vaccines Sales by Country (2021-2026)
  4. 10.1.3 South America Vaccines Sales Forecast by Country (2027-2032)
  5. 10.2 South America Vaccines Market Size by Country
  6. 10.2.1 South America Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Vaccines Market Size by Country (2021-2026)
  8. 10.2.3 South America Vaccines Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Vaccines Sales by Country
  2. 11.1.1 Middle East and Africa Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Vaccines Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Vaccines Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Vaccines Market Size by Country
  6. 11.2.1 Middle East and Africa Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Vaccines Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Vaccines Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Vaccines Value Chain Analysis
  2. 12.1.1 Vaccines Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Vaccines Production Mode & Process
  7. 12.2 Vaccines Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Vaccines Distributors
  10. 12.2.3 Vaccines Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst